Patient-Reported Outcomes To Be Topic Of February Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA plans to issue a draft guidance on patient-reported outcomes, which will be the subject of a joint FDA/Mayo Clinic meeting Feb. 23-25.
You may also be interested in...
Patient-Reported Outcomes Data Can Be Used In Labeling, FDA Draft Guidance Says
Document outlines the evaluation and development of appropriate PRO instruments to collect outcomes data that supports labeling claims.
Nexavar “Very Competitive” With Pfizer’s Sutent, Bayer Says
Bayer’s kidney cancer drug brought in $25.2 mil. (€20 mil.) in the first quarter following its approval late last year.